Blood vessel access and closure devices and related methods of use

Information

  • Patent Grant
  • 11529130
  • Patent Number
    11,529,130
  • Date Filed
    Tuesday, January 23, 2018
    6 years ago
  • Date Issued
    Tuesday, December 20, 2022
    a year ago
  • Inventors
  • Original Assignees
    • J.D. Franco & Co., LLC (Plano, TX, US)
  • Examiners
    • Jamialahmadi; Majid
    Agents
    • Bookoff McAndrews, PLLC
Abstract
A medical device may include an outer assembly having a first shaft, a first lumen extending through the first shaft, and an atraumatic first tip removably coupled to a distal end of the first shaft; an inner assembly configured to extend through the first lumen of the outer assembly, the inner assembly including a second shaft, a second lumen extending through the second shaft, and a second tip removably coupled to a distal end of the second shaft, the second tip being configured to pierce tissue; and a plug assembly configured to extend through the second lumen of the inner assembly, the plug assembly including a third shaft and a plug removably coupled to a distal end of the third shaft.
Description
TECHNICAL FIELD

Embodiments of the present disclosure relate to devices for accessing a blood vessel by creating an opening through a wall of the blood vessel, and for subsequently closing the opening, and related methods of use.


BACKGROUND

Various mechanisms are available for accessing a blood vessel in order to perform a medical procedure inside the blood vessel or other part of the cardiovascular system. However, many conventional techniques position a sheath or other member within the blood vessel, restricting the field of view within the vessel, and restricting the ability to navigate tools both proximally and distally of the point of insertion. Additionally, procedure times for conventional techniques may be higher than optimal.


SUMMARY

In one aspect, the disclosure is directed to a medical device including an outer assembly having a first shaft, a first lumen extending through the first shaft, and an atraumatic first tip removably coupled to a distal end of the first shaft; an inner assembly configured to extend through the first lumen of the outer assembly, the inner assembly including a second shaft, a second lumen extending through the second shaft, and a second tip removably coupled to a distal end of the second shaft, the second tip being configured to pierce tissue; and a plug assembly configured to extend through the second lumen of the inner assembly, the plug assembly including a third shaft and a plug removably coupled to a distal end of the third shaft.


The first tip may include a first tip lumen, the second tip may extend through the first tip lumen, and the second tip may include a protrusion configured to engage with the first tip and secure the first tip to the second tip. The protrusion may extend proximally from a proximal end of the second tip, and is configured to engage with a proximal end of the first tip via a snap-fit. The first tip may include a first bevel at a distal end of the first tip. The second tip may include a second bevel configured to pierce tissue at a distal end of the second tip. The second tip may include a first flange extending proximally from the second bevel at an angle offset from a longitudinal axis of the second tip. The first flange may include a first part and a second part pivotable relative to the first part by a hinge. In a first configuration, the second part may extend at a first angle to the longitudinal axis of the second tip, and in a second configuration, the second part may extend at a second angle to the longitudinal axis of the second tip, wherein the second angle is different than the first angle. Pulling the inner assembly proximally may cause the second part to pivot from the first configuration to the second configuration. The hinge may be a living hinge. The second tip may include a second tip lumen extending through the second tip, an inner surface surrounding a distal portion of the second tip lumen, and a second flange extending radially inward from the inner surface and surrounding a proximal portion of the second tip lumen. The plug may be a solid member without lumens, may include a bevel at a distal end, and may include a third flange extending circumferentially around a portion of the plug, wherein a distally-facing surface of the third flange is configured to abut a proximal-facing surface of the second flange when the plug is extended through the second lumen. The second tip may include a recess at a distal end of the second tip, the recess extending only partially around a circumference of the second tip, and the plug may include a protrusion configured to be received by the recess, the protrusion extending only partially around a circumference of the plug. One or more of the first tip, the second tip, and the plug may be bioresorbable. Each of the first tip, the second tip, and the plug may be bioresorbable.





BRIEF DESCRIPTION OF THE DRAWINGS

The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate various exemplary embodiments and together with the description, serve to explain the principles of the disclosed embodiments.



FIGS. 1-3, 3A, and 4-6 illustrate a method of accessing a blood vessel for a procedure, and for sealing the blood vessel after the procedure.



FIG. 7 illustrates various components of a medical kit according to an example of the present disclosure.



FIGS. 8-12 illustrate an inner assembly having a piercing tip according to an example of the present disclosure.



FIGS. 13-18 illustrate an outer assembly having a distal tip according to an example of the present disclosure.



FIGS. 19-24 illustrate a plug assembly having a plug according to an example of the present disclosure.



FIGS. 25-30 illustrate the inner assembly of FIGS. 8-12, the outer assembly of FIGS. 13-18, and the plug assembly of FIGS. 19-24 used together in various configurations.



FIG. 31 is a schematic illustration of an example of closing an opening to a blood vessel using a suture.



FIG. 32 is a schematic illustration of accessing a blood vessel using multiple sheaths.



FIG. 33 is a schematic illustration of a filter assembly in a blood vessel.



FIGS. 34-36 illustrate another embodiment of a piercing tip for use with an inner assembly.





DETAILED DESCRIPTION

Reference will now be made in detail to exemplary embodiments of the present disclosure, examples of which are illustrated in the accompanying drawings. Wherever possible, the same reference numbers will be used throughout the drawings to refer to the same or like parts or components. The term “distal” refers to the direction that is away from the user or operator and into the patient's body. By contrast, the term “proximal” refers to the direction that is closer to the user or operator and away from the patient's body.


The present disclosure is directed to devices for accessing a blood vessel, such as, e.g., a femoral artery, a carotid artery, or any other artery or vein. An exemplary method is shown in FIGS. 1-3, 3A, and 4-6 using a medical kit. The medical kit is described in more detail with reference to FIGS. 7-30.


Referring to FIG. 7, the medical kit may include an inner assembly 100, an outer assembly 200, a plug assembly 300, and a dilator 400. Dilator 400 may be any suitable device configured to dilate a body lumen, including expandable dilators. Dilator 400 may be removably coupled to inner assembly 100 so that dilator 400 and inner assembly 100 may be inserted simultaneously into a blood vessel.


Various portions of inner assembly 100 are shown in FIGS. 8-12. Inner assembly 100 may extend from a proximal end 102 to a distal end 104, and may include a shaft 106 that is coupled to a piercing tip 108 at distal end 104. The shaft 106 may include one or more lumens extending therethrough. Shaft 106 also may include one or more openings 110 extending through a wall of shaft 106. In one example, shaft 106 may include two diametrically opposed openings 110 near its distal end.


Piercing tip 108 has a body that extends from a proximal end 109 to a distal end 110, and may include a bevel 111 at distal end 110 that is configured to pierce through tissue. Piercing tip 108 also may include a flange 112 that extends proximally from bevel 111. In some examples, flange 112 may lie in the same plane as bevel 111. In some examples, flange 112 extends from only a proximal portion of bevel 111. Flange 112, and particularly its proximal-facing surface, may include a tacky coating and/or bioadhesive to help maintain flange 112 against tissue. A lumen 113 may extend from proximal end 109 to distal end 110. Piercing tip 108 may include a circumferential rim 114 at proximal end 109, and a circumferential flange 116 disposed distally of rim 114. The flange 116 may extend radially inward from an inner surface 118 of piercing tip 108. The flange 116 may have a smaller diameter than rim 114. A locking arm 120 may extend proximally from rim 114. Locking arm 120 may include a radially-outward extending protrusion 121. Piercing tip 108 also may include a recess 122 at distal end 110, which may be used in a snap fit engagement with a portion of plug assembly 300, as discussed in further detail below. Piercing tip 108 also may include one or more openings 124 extending through its body and in communication with lumen 113. In one example, piercing tip 108 may include diametrically opposed openings 124 that align with openings 110 of shaft 106.


Piercing tip 108 may be coupled to a distal end of shaft 106 via a connecting member 130. The connecting member 130 may extend outside of the one or more lumens of shaft 106 and through openings 110 of shaft 106 and openings 124 of piercing tip 108, to secure the piercing tip 108 to shaft 106. The connecting member 130 may be a suture, wire, thread, or other suitable connecting member. Opposing ends 132 of connecting member 130 may extend proximally when piercing tip 108 and shaft 106 are coupled to one another. In one example, tension may be applied to those ends 132. Piercing tip 108 may be configured to detach from shaft 106. In one example, tension may be released from one of the ends 132, allowing connecting member 130 to be removed from the device by pulling on the other end 132. In another example, connecting member 130 may include one or more frangible links that are configured to break when a sufficient pulling force is applied to ends 132, allowing separation of piercing tip 108 from shaft 106.


Referring to FIG. 7, inner assembly 100 may include an access port 150 and a conduit 152 at proximal end 102. Access port 150 may be used to deliver various tools through one or more lumens of inner assembly 100, and conduit 152 may be used for suction, irrigation, aspiration, or other fluid-related tasks. In one example, conduit 152 may be used to provide a saline flush. A pressure sensor may disposed in access port 150 or in another suitable location of inner assembly 100 to monitor pressure within a blood vessel.


Various portions of outer assembly 200 are shown in FIGS. 13-18. Outer assembly 200 may extend from a proximal end 202 to a distal end 204, and may include a shaft 206 that is coupled to a distal tip 208 at distal end 204. The shaft 206 may include one or more lumens extending therethrough. Shaft 206 also may include one or more openings 210 extending through a wall of shaft 206. In one example, shaft 206 may include two diametrically opposed openings 210 near its distal end.


Distal tip 208 has a body that extends from a proximal end 209 to a distal end 210, and may include a bevel 211 at distal end 210 that is configured to clamp onto tissue. In some examples, the bevel 211 may be atraumatic to prevent excessive damage to tissue when used as a clamp. Bevel 211 may include a tacky coating and/or bioadhesive in order to help secure bevel 211 against tissue. A gauze or other fabric may be coupled to bevel 211 to absorb excess bodily fluids and to facilitate healing during closure of an access opening to a blood vessel. Proximal end 209 may include a generally cylindrical portion 215 configured to slide into a lumen of shaft 206. Distal tip 208 also may include a proximally-facing circumferential flange 212 configured to abut the distal end of shaft 206. A lumen 213 may extend from proximal end 209 to distal end 210. Distal tip 208 also may include one or more openings 224 extending through cylindrical portion 215 and in communication with lumen 213. In one example, distal tip 208 may include diametrically opposed openings 224 that align with openings 210 of shaft 206.


Distal tip 208 may be coupled to a distal end of shaft 206 via a connecting member 130 that is substantially similar to the connecting member 130 previously described. The connecting member 130 may extend through openings 224 of distal tip 208 and at least partially around a circumference of cylindrical portion 215. The ends 132 of the connecting member 130 then may be passed through openings 210 of shaft 206, the lumen of shaft 206, and proximally out of shaft 206.


Various portions of plug assembly 300 are shown in FIGS. 19-24. Plug assembly 300 may extend from a proximal end 302 to a distal end 304, and may include a shaft 306 that is coupled to a plug 308 at distal end 304. The shaft 306 may include one or more lumens extending therethrough. Shaft 306 also may include one or more openings 310 extending through a wall of shaft 306. In one example, shaft 306 may include two diametrically opposed openings 310 near its distal end.


Plug 308 has a body that extends from a proximal end 309 to a distal end 310, and may include a bevel 311 at distal end 310. In some examples, the bevel 311 may be a solid member (having no lumens or extensions therethrough) in order to seal an opening created through a wall of a blood vessel. Proximal end 309 may include a generally cylindrical portion 315 configured receive a distal end of shaft 306 in a lumen 313. Distal tip 308 also may include a circumferential flange 312 configured to abut flange 116 of inner assembly 100. Lumen 313 may extend from proximal end 309 toward distal end 310, and may be closed off at a distal end by a proximal surface of bevel 311. Plug 308 also may include one or more openings 324 extending through cylindrical portion 315 and in communication with lumen 313. In one example, plug 308 may include diametrically opposed openings 324 that align with openings 310 of shaft 306. Plug 308 also may include a locking protrusion 330 extending radially outward from a proximalmost portion of the bevel 311. As shown in FIG. 22, plug 308 may be covered with a graft 340, such as, e.g., an ePTFE graft to promote tissue growth after insertion through a blood vessel wall.


Distal tip 308 may be coupled to a distal end of shaft 306 via a connecting member 130 that is substantially similar to the connecting member 130 previously described. The connecting member 130 may extend through openings 324 of plug 308 and at least partially around a circumference of cylindrical portion 315. The ends 132 of the connecting member 130 then may be passed through openings 310 of shaft 306, a lumen of shaft 306, and proximally out of shaft 306.


All or portions of inner assembly 100, outer assembly 200, and plug assembly 300 may be formed from biocompatible materials. Examples of such materials may include, but are not limited to, polytetrafluoroethylene (PTFE), expanded polytetrafluoroethylene (ePTFE), ethylene tetrafluoroethylene (ETFE), polyethylene terephthalate (PET), perfluoroalkoxy (PFA), polyether ether ketone (PEEK), polypropylene (PP), silicone, polycarbonate, polyurethane, LDPE, HDPE or the like. In some embodiments, one or more portions of the inner assembly 100, outer assembly 200, and plug assembly 300, may be formed from bioresorbable materials, including, for example, polyglycolide (PGA), polylactide (PLA), and/or polycaprolactone (PCL). When bioresorbable materials are used, different bioresorbable materials may be used that regrade at different rates. In one example, one or more of piercing tip 108, distal tip 208, and plug 308 may include a bioresorbable material.



FIGS. 25-30 show the relationship of inner assembly 100, outer assembly 200, and plug assembly 300. In one example, outer assembly 200 may be configured to surround inner assembly 100, and thus, inner assembly 100 may have a smaller diameter than outer assembly 200 so as to fit within a lumen of outer assembly 200. Further, plug assembly 300 may be configured to slide within a lumen of inner assembly 100 as shown in FIG. 25. Thus, shafts 206, 106, and 306 may be nested in certain configurations of the medical kit. Additionally, distal tip 208, piercing tip 108, and plug 308 may be nested in certain configurations, with distal tip 208 surrounding piercing tip 108, and piercing tip 108 surrounding plug 308.


Distal tip 208 and piercing tip 108 may have corresponding features that cooperate to secure distal tip 208 and piercing tip 108 together. For example, locking arm 120 of inner assembly 100 may be configured to engage proximal end 209 of distal tip 208. For example, distal tip 208 may be advanced distally over piercing tip 108 until locking arm 120 clears proximal end 209 of distal tip 208, causing distal tip 208 and piercing tip 108 to form a locked configuration relative to one another. The protrusion 121 of locking arm 120 may engage proximal end 209 of distal tip 208. Also, locking arm 120 may be a cantilevered arm that may flex radially inward and outward during engagement with distal tip 208. Once locking arm 120 clears proximal end 209, piercing tip 108 may be prevented from moving distally relative to distal tip 208 due to the engagement of locking arm 120 with proximal end 209 of distal tip 208.


Piercing tip 108 and plug 308 also may have corresponding features that cooperate to secure piercing tip 108 to plug 308. For example, piercing tip 108 includes a recess 122 configured to receive locking protrusion 330 of plug 308. Also, flange 116 of piercing tip 108 may be configured to abut the distally-facing surface of flange 312. Thus, in some examples, plug 308 may be advanced distally through the proximal end 109 of piercing tip 108 until locking protrusion 330 engages with recess 122. Once locking protrusion 330 engages with recess 122, plug 308 may be prevented from moving proximally relative to piercing tip 108 due to the engagement of locking protrusion 330 and recess 122. In some examples, the engagement of locking protrusion 330 with recess 122 may require precise circumferential alignment between piercing tip 108 and plug 308. Additionally, plug 308 may be prevented from moving distally relative to piercing tip 108 due to the engagement of flange 116 and flange 312.



FIGS. 1-6 illustrate a method of accessing a blood vessel 1000 using the medical kit described with reference to FIGS. 7-30. Referring to FIG. 1, the method may begin with the kit in an insertion configuration where outer assembly 200 is positioned around inner assembly 100. Blood vessel 1000 may first be accessed by guidewire 500 through an opening made by any suitable puncture device (not shown), and then inner assembly 100, outer assembly 200, and dilator 400 may be advanced separately or simultaneously over guidewire 500. Once dilator 400 pierces through blood vessel wall 1002, blood may enter a side-hole of dilator 400 and travel proximally through dilator 400 so as to be visible at proximal end 102, providing a visual indication that the blood vessel 1000 has been accessed by dilator 400. Then, blood vessel 1000 may be accessed by piercing a wall 1002 with piercing tip 108 (and inner assembly 100) in a bevel up configuration where the bevel 111 faces away from the operator. Outer assembly 200 also may be in a bevel up configuration while piercing tip 108 is in the bevel up configuration. In a bevel up configuration, piercing tip 108 may initially contact tissue only with its distalmost point, whereas, in a bevel down configuration, the face of bevel 111 may make initial contact with tissue. In the bevel down configuration, the proximalmost portion of bevel 111 may contact tissue before, or at the same time, as a distalmost portion of bevel 111.


Referring to FIG. 2, an operator may rotate inner assembly 100 and/or outer assembly 200 after blood vessel 1000 has been accessed by piercing tip 108 such that both inner assembly 100 and outer assembly 200 are in a bevel down configuration where bevel 111 and 211 face toward from the user. In some embodiments, inner assembly 100 may not be rotated after blood vessel 1000 is accessed by piercing tip 108.


Referring to FIG. 3, once piercing tip 108 is in the bevel down configuration within blood vessel 1000, inner assembly 100 may be pulled proximally to cause flange 112 to abut the inner surface of blood vessel wall 1002. As alluded to above, inner assembly 100 may not be rotated after piercing tip 108 accesses blood vessel 1000, and inner assembly 100 may be pulled proximally while piercing tip 100 is in the bevel up configuration to cause flange 112 to abut the inner surface of blood vessel wall 1002. In some examples, the operator may be required to maintain a proximal pulling force on inner assembly 100. However, in other examples, a proximal pulling force may be maintained by various mechanical or electromechanical mechanisms so that the operator is free to perform other tasks. Referring to FIG. 3A, once flange 112 is secured against the inner surface of blood vessel wall 1002, outer assembly 200 may be pushed down (distally) such that bevel 211 (and distal tip 208 of outer assembly) comes into contact with skin or the outer surface of blood vessel wall 1002, forming a clamp with piercing tip 108. As outer assembly 200 is pushed distally, locking arm 120 (and protrusion 121) of inner assembly 100 may engage proximal end 209 of distal tip 208, securing piercing tip 108 and distal tip 208 together. Once locking arm 120 is engaged with proximal end 209 of outer assembly 200, piercing tip 108 may be prevented from moving distally relative to distal tip 208. Piercing tip 108 also may be prevented from moving further proximally due to the engagement of flange 112 with the inner surface of blood vessel wall 1002. Tacky coatings and/or bioadhesives applied to the surfaces of flange 112 and bevel 211 also may help secure piercing tip 108 and distal tip 208 in place during closure of the opening in blood vessel wall 1002.


Once piercing tip 108 and distal tip 208 are secured to one another, dilator 400 and guidewire 500 may be removed from a lumen of inner assembly 100 (FIG. 4), and a suitable therapeutic or diagnostic procedure may be performed in blood vessel 1000. The procedure may be performed in the absence of any sheath, scope, or other tool within blood vessel 1000. This may allow for easier manipulation of tools within blood vessel 1000, and for procedures to be performed both proximally and distally of the opening created in blood vessel wall 1002.


After completion of the procedure, the tools used during the procedure may be removed from blood vessel 1000, and plug assembly 300 may be inserted through inner assembly 100 (FIG. 5) until plug 308 engages with piercing tip 108 to close the opening. As set forth above, locking protrusion 330 of plug 308 may engage with recess 122 of piercing tip 108. Also, flange 116 of piercing tip 108 may be abut the distally-facing surface of flange 312 to prevent plug 308 from entering blood vessel 1000.


Once piercing tip 108, distal tip 208, and plug 308 are engaged with one another, shafts 106, 206, and 306 may be removed by pulling on connecting member ends 132 as described above. Thus, after completion of the procedure, a closure device comprising only piercing tip 108, distal tip 208, and plug 308 may remain coupled to the blood vessel wall 1002. In some examples, the entirety of the closure device may resorb within 30 to 90 days. In other examples, where the components of the closure device are non-resorbable, the closure device may be removed in a subsequent procedure, if desired.


In an alternative example shown in FIG. 31, distal tip 208 may not be used to close the opening through blood vessel wall 1002. Instead, distal tip 208 and the remainder of outer assembly 200 may be retracted proximally and/or otherwise detached from inner assembly 100 (or not used at all), and a suture knot 3102 may be used to close the opening after plug 308 has been inserted through the opening. Collagen, hydrogel, or another suitable dressing 3104 may be applied to the opening and/or suture knot 3102 to facilitate healing.


In another example shown in FIG. 32, a second procedural sheath 3202 may be inserted through inner assembly 100 and into blood vessel 1000. The second procedural sheath may direct and/or divert catheters, tools, and other medical devices into the blood vessel 1000 and may help prevent puncture of an opposing surface of blood vessel wall 1002.


In yet another example shown in FIG. 33, a filter system 3300 may be placed into blood vessel 1000 downstream of the opening through blood vessel wall 1002. Placement of the filter system 3300 downstream of the opening may help capture tissue or other materials that come loose and enter the bloodstream, helping to prevent an embolism caused by the loose materials. In one example, the filter system 3300 is used when blood vessel 1000 is the carotid artery.



FIGS. 34-36 illustrate another embodiment of a piercing tip for use with an inner assembly in the same way that other piercing tips are used with an inner assembly throughout this disclosure. Piercing tip 608 has a body that extends from a proximal end 609 to a distal end 610, and may include a bevel 611 at distal end 610 that is configured to pierce through tissue. Piercing tip 608 also may include a flange 612 that extends proximally from bevel 611. Flange 612 will be described in more detail below. A lumen 613 may extend from proximal end 609 to distal end 610. Piercing tip 608 may include a circumferential rim 614 at proximal end 609, and a circumferential flange (not shown) disposed distally of rim 614, as in embodiments described above. The circumferential flange may have the characteristics and structure of the like-flange described in connection with those other embodiments. Two locking arms 620 extend proximally from rim 614, 180 degrees apart from each other. Each locking arm 620 includes a radially-outward extending protrusion 621. Piercing tip 108 also may include a recess 622 at distal end 610, which may be used in a snap fit engagement with a portion of plug assembly 300, as discussed in further detail above. Piercing tip 608 also may include one or more openings 624 extending through its body and in communication with lumen 613, for the same purposes as like-openings described in connection with other embodiments within this disclosure. In an example, piercing tip 608 may include diametrically opposed openings 624 that align with openings 110 of shaft 106.


As shown in FIGS. 34-36, flange 612 includes two parts 612a and 612b coupled together by a pivot/hinge 612c. Parts 612a, 612b and hinge 612c may be constructed as a one-piece, integral structure (for example, molded) or as multiple pieces coupled together by, for example, a pivot pin. If a one piece structure, hinge 612c may be a living hinge, permitting pivoting of part 612a relative to part 612b. Piercing tip 608 may be made of any suitable biocompatible material, including bioresorbable materials or materials suitable for a permanent implant. It is contemplated that flange 612 may extend around a greater portion of the circumference of piercing tip 608 than is shown in the figures. For example, flange 612 may extend around a majority of the circumference of piercing tip 608, or multiple flanges 612 may extend around the circumference of piercing tip 608. When multiple flanges 612 are utilized, a majority of the circumference of piercing tip 608 may be encompassed by at least one of the flanges 612. Furthermore, while two parts (612a and 612b) and one hinge (612c) are shown, a given flange 612 may include additional parts and/or hinges. For example, one flange 612 may include three parts pivotable relative to one another by two hinges. These combinations are only exemplary. Other numbers of parts and flanges also are contemplated. In yet other embodiments, only a minority of the circumference of piercing tip 608 may be covered by a flange 612.


As shown in FIG. 36, piercing tip 608 is configured to have a first, insertion configuration suitable for insertion of piercing tip through the blood vessel wall. In that configuration, flange 612 assumes a bent profile, limiting the overall cross-sectional width of tip 608. In that profile, part 612a is pivoted relative to part 612b, and out of the plane of part 612b, Part 612a assumes a position aligned with the longitudinal axis of the lumen 613 of tip 608, and adjacent to the outer surface of the body of tip 608.


After insertion of tip 608 within the blood vessel, and pulling back of tip 608, part 612a will snag against the inner surface of the vessel wall, causing part 612a to pivot relative to part 612b and assume the second implanted configuration shown in FIGS. 34 and 35. Flange 612 may be configured so that part 612a cannot rotate past the plane of part 612b, for example by using a living hinge as hinge 612c. Flange 612, and particularly its proximal-facing surface, may include a tacky coating and/or bioadhesive to help maintain flange 612 against tissue.


Embodiments of the present disclosure may increase the speed of access into the neck for stroke treatments, and also speed up procedural times during other procedures, such as, e.g., femoral access. The angled shape of piercing tip 108 may allow for access into an artery (or other blood vessel) and provide a larger footprint for inside artery securement.


Although the exemplary embodiments described above have been disclosed in connection with medical devices for insertion into a blood vessel, those skilled in the art will understand that the principles set out above can be applied to any body lumen and can be implemented in different ways without departing from the scope of the disclosure as defined by the claims. In particular, constructional details, including manufacturing techniques and materials, are well within the understanding of those of skill in the art and have not been set out in any detail here. These and other modifications and variations are well within the scope of the present disclosure and can be envisioned and implemented by those of skill in the art.


Other exemplary embodiments of the present disclosure will be apparent to those skilled in the art from consideration of the specification and practice of the exemplary embodiments disclosed herein. It is intended that the specification and examples be considered as exemplary only, and departures in form and detail may be made without departing from the scope and spirit of the present disclosure as defined by the following claims.

Claims
  • 1. A medical device, comprising: an outer assembly having a first shaft, a first lumen extending through the first shaft, and an atraumatic first tip removably coupled to a distal end of the first shaft;an inner assembly configured to extend through the first lumen of the outer assembly, the inner assembly including a second shaft, a second lumen extending through the second shaft, and a second tip removably coupled to a distal end of the second shaft, the second tip being configured to pierce tissue; anda plug assembly configured to extend through the second lumen of the inner assembly, the plug assembly including a third shaft and a plug removably coupled to a distal end of the third shaft.
  • 2. The medical device of claim 1, wherein: the first tip includes a first tip lumen;the second tip extends through the first tip lumen; andthe second tip includes a protrusion configured to engage with the first tip and secure the first tip to the second tip.
  • 3. The medical device of claim 2, wherein the protrusion extends proximally from a proximal end of the second tip, and is configured to engage with a proximal end of the first tip via a snap-fit.
  • 4. The medical device of claim 1, wherein the first tip includes a first bevel at a distal end of the first tip.
  • 5. The medical device of claim 4, wherein the second tip includes a second bevel configured to pierce tissue at a distal end of the second tip.
  • 6. The medical device of claim 5, wherein the second tip includes a first flange extending proximally from the second bevel at an angle offset from a longitudinal axis of the second tip.
  • 7. The medical device of claim 6, wherein the first flange includes a first part and a second part pivotable relative to the first part by a hinge.
  • 8. The medical device of claim 7, wherein: in a first configuration, the second part extends at a first angle to the longitudinal axis of the second tip; andin a second configuration, the second part extends at a second angle to the longitudinal axis of the second tip, wherein the second angle is different than the first angle.
  • 9. The medical device of claim 8, wherein pulling the inner assembly proximally causes the second part to pivot from the first configuration to the second configuration.
  • 10. The medical device of claim 7, wherein the hinge is a living hinge.
  • 11. The medical device of claim 1, wherein the second tip includes: a second tip lumen extending through the second tip;an inner surface surrounding a distal portion of the second tip lumen; anda second flange extending radially inward from the inner surface and surrounding a proximal portion of the second tip lumen.
  • 12. The medical device of claim 11, wherein the plug: is a solid member without lumens;includes a bevel at a distal end of the plug; andincludes a third flange extending circumferentially around a portion of the plug, wherein a distally-facing surface of the third flange is configured to abut a proximal-facing surface of the second flange when the plug is extended through the second lumen.
  • 13. The medical device of claim 1, wherein: the second tip includes a recess at a distal end of the second tip, the recess extending only partially around a circumference of the second tip; andthe plug includes a protrusion configured to be received by the recess, the protrusion extending only partially around a circumference of the plug.
  • 14. The medical device of claim 1, wherein one or more of the first tip, the second tip, and the plug are bioresorbable.
  • 15. The medical device of claim 1, wherein each of the first tip, the second tip, and the plug are bioresorbable.
  • 16. The medical device of claim 1, wherein the second tip has: a body extending from a proximal end of the second tip to a distal end of the second tip;a circumferential rim at the proximal end of the second tip;a bevel at the distal end of the second tip, a face of the bevel extending at an angle relative to a longitudinal axis of the body; anda bevel flange extending proximally from the bevel.
  • 17. A method, comprising: advancing an inner assembly through a blood vessel wall of a subject, the inner assembly including a first beveled tip removably coupled to a first shaft, the first beveled tip defining an opening and including a flange at a first end thereof and a tip end at a second end thereof, wherein the advancing the inner assembly includes advancing the inner assembly in a first bevel configuration in which the tip end is positioned toward the blood vessel wall and the flange is positioned away from the blood vessel wall;proximally retracting the inner assembly such that the flange abuts an interior surface of the blood vessel wall;advancing an outer assembly distally toward the blood vessel wall, wherein the outer assembly includes a second beveled tip removeably coupled to a second shaft, wherein the advancing the outer assembly includes advancing the outer assembly until the second beveled tip contacts a skin of the subject or an exterior surface of the blood vessel wall;coupling the first beveled tip to the second beveled tip so as to clamp tissue therebetween;delivering a plug assembly through the inner assembly until a plug of the plug assembly engages the first beveled tip, thereby closing the opening, the plug assembly including the plug removably coupled to a plug shaft; andremoving the first shaft from the first beveled tip, the second shaft from the second beveled tip, and the plug shaft from the plug.
  • 18. The method of claim 17, wherein coupling the first beveled tip to the second beveled tip includes coupling a proximal locking arm of the first beveled tip to a proximal end of the second beveled tip.
  • 19. The method of claim 18, wherein the proximal locking arm includes a protrusion configured to abut the proximal end of the second beveled tip.
  • 20. The method of claim 18, wherein the proximal locking arm is cantilevered.
  • 21. The method of claim 17, further including, before the advancing the outer assembly distally, rotating the inner assembly toward a second bevel configuration, wherein in the second bevel configuration, the tip end is positioned away from the blood vessel wall and the flange is positioned toward the blood vessel wall.
  • 22. The method of claim 21, wherein in the first bevel configuration, the tip end of the first beveled tip is configured to contact tissue prior to a bevel face of the first beveled tip, and wherein in the second bevel configuration, the bevel face of the first beveled tip is configured to contact tissue prior to, or at the same time as, the tip end of the first beveled tip.
  • 23. The method of claim 17, further including coupling the plug of the plug assembly to the first beveled tip via engagement between a locking protrusion of the plug with a recess of the first beveled tip.
  • 24. The method of claim 17, wherein the first beveled tip, the second beveled tip, and the plug are bioresorbable.
  • 25. The method of claim 17, wherein the advancing the outer assembly distally includes advancing the outer assembly over the inner assembly such that at least a portion of the inner assembly is received within a lumen of the outer assembly.
  • 26. A method, comprising: advancing an inner assembly through a target tissue wall of a subject, the inner assembly including a first beveled tip removably coupled to a first shaft, the first beveled tip defining an opening and including a flange at a first end thereof and a tip end at a second end thereof, wherein the advancing the inner assembly includes advancing the inner assembly in a first bevel configuration in which the tip end is positioned so as to contact the target tissue wall before the flange;rotating the inner assembly toward a second bevel configuration, wherein in the second bevel configuration, the flange is positioned so as to contact the target tissue wall before, or at the same time as, the tip end;proximally retracting the inner assembly such that the flange abuts an interior surface of the target tissue wall;advancing an outer assembly distally toward the target tissue wall over the inner assembly, wherein the outer assembly includes a second beveled tip removeably coupled to a second shaft, wherein the advancing the outer assembly includes advancing the outer assembly until the second beveled tip contacts a skin of the subject or an exterior surface of the target tissue wall;coupling the first beveled tip to the second beveled tip so as to clamp tissue therebetween;delivering a plug assembly through the inner assembly until a plug of the plug assembly engages the first beveled tip, thereby closing the opening, the plug assembly including the plug removably coupled to a plug shaft; andremoving the first shaft from the first beveled tip, the second shaft from the second beveled tip, and the plug shaft from the plug.
  • 27. The method of claim 26, wherein the coupling of the first beveled tip to the second beveled tip includes coupling a proximal locking arm of the first beveled tip to a proximal end of the second beveled tip.
  • 28. The method of claim 27, wherein the proximal locking arm includes a protrusion configured to abut the proximal end of the second beveled tip.
  • 29. The method of claim 27, wherein the proximal locking arm is cantilevered.
CROSS-REFERENCE TO RELATED APPLICATIONS

This patent application is the U.S. national phase entry under 35 U.S.C. § 371 of International PCT Patent Application No. PCT/US2018/014766, filed Jan. 23, 2018, which claims the benefits of priority under 35 U.S.C. § 119 to U.S. Provisional Patent Application No. 62/450,257, filed Jan. 25, 2017, and to U.S. Provisional Application No. 62/525,839, filed Jun. 28, 2017, the entireties of each of U.S. Provisional Application Nos. 62/450,257 and 62/525,839 are incorporated herein by reference.

PCT Information
Filing Document Filing Date Country Kind
PCT/US2018/014766 1/23/2018 WO
Publishing Document Publishing Date Country Kind
WO2018/140371 8/2/2018 WO A
US Referenced Citations (165)
Number Name Date Kind
2690595 Raiche Oct 1954 A
3367101 Garnet et al. Feb 1968 A
3435826 Fogarty Apr 1969 A
3970090 Loiacono Jul 1976 A
4224929 Furihata Sep 1980 A
4403612 Fogarty Sep 1983 A
4445897 Ekbladh et al. May 1984 A
4794931 Yock Jan 1989 A
4857045 Rydell Aug 1989 A
4886061 Fischell et al. Dec 1989 A
4894051 Shiber Jan 1990 A
4898575 Fischell et al. Feb 1990 A
4926858 Gifford, III et al. May 1990 A
4936835 Haaga Jun 1990 A
4950277 Faar Aug 1990 A
4957482 Shiber Sep 1990 A
4979939 Shiber Dec 1990 A
4986807 Faar Jan 1991 A
5000185 Yock Mar 1991 A
5000734 Boussignac et al. Mar 1991 A
5007896 Shiber Apr 1991 A
5019088 Faar May 1991 A
5024651 Shiber Jun 1991 A
5026384 Farr et al. Jun 1991 A
5087265 Summers Feb 1992 A
5100425 Fischell et al. Mar 1992 A
5135531 Shiber Aug 1992 A
5176693 Pannek, Jr. Jan 1993 A
5292332 Lee Mar 1994 A
5313949 Yock May 1994 A
5314438 Shturman May 1994 A
5318576 Plassche et al. Jun 1994 A
5336234 Vigil et al. Aug 1994 A
5366464 Belknap Nov 1994 A
5395311 Andrews Mar 1995 A
5402790 Jang et al. Apr 1995 A
5409454 Fischell et al. Apr 1995 A
5415634 Glynn et al. May 1995 A
5419761 Narayanan et al. May 1995 A
5507292 Jang et al. Apr 1996 A
5554119 Harrison et al. Sep 1996 A
5709701 Parodi Jan 1998 A
5820595 Parodi Oct 1998 A
5897567 Ressemann et al. Apr 1999 A
5951514 Sahota Sep 1999 A
5972019 Engelson et al. Oct 1999 A
6010522 Barbut et al. Jan 2000 A
6146370 Barbut Nov 2000 A
6206868 Parodi Mar 2001 B1
6302908 Parodi Oct 2001 B1
6336933 Parodi Jan 2002 B1
6344054 Parodi Feb 2002 B1
6413235 Parodi Jul 2002 B1
6423032 Parodi Jul 2002 B2
6494890 Shturman et al. Dec 2002 B1
6540712 Parodi et al. Apr 2003 B1
6595980 Barbut Jul 2003 B1
6623471 Barbut Sep 2003 B1
6626861 Hart et al. Sep 2003 B1
6641573 Parodi Nov 2003 B1
6645222 Parodi et al. Nov 2003 B1
6824558 Parodi Nov 2004 B2
6827726 Parodi Dec 2004 B2
6837881 Barbut Jan 2005 B1
6855162 Parodi Feb 2005 B2
6902540 Dorros et al. Jun 2005 B2
6905490 Parodi Jun 2005 B2
6908474 Hogendijk et al. Jun 2005 B2
6929634 Dorros et al. Aug 2005 B2
6936053 Weiss Aug 2005 B1
6936060 Hogendijk et al. Aug 2005 B2
6974469 Broome et al. Dec 2005 B2
7195611 Simpson et al. Mar 2007 B1
7214201 Burmeister et al. May 2007 B2
7235095 Haverkost et al. Jun 2007 B2
7309334 Von Hoffmann Dec 2007 B2
7384411 Condado Jun 2008 B1
7604612 Ressemann et al. Oct 2009 B2
7806906 Don Michael Oct 2010 B2
7867273 Pappas et al. Jan 2011 B2
7901445 Wallace et al. Mar 2011 B2
7918800 Brown Apr 2011 B1
7927347 Hogendijk et al. Apr 2011 B2
8123779 Demond et al. Feb 2012 B2
8157760 Criado et al. Apr 2012 B2
8267956 Salahieh et al. Sep 2012 B2
8353850 Ressemann et al. Jan 2013 B2
8409237 Galdonik et al. Apr 2013 B2
8414516 Chang Apr 2013 B2
8439937 Montague et al. May 2013 B2
8545432 Renati et al. Oct 2013 B2
8834404 Beaudin Sep 2014 B2
8852226 Gilson et al. Oct 2014 B2
8863631 Janardhan et al. Oct 2014 B1
9078682 Lenker et al. Jul 2015 B2
9241699 Kume et al. Jan 2016 B1
9259215 Chou et al. Feb 2016 B2
9265512 Garrison et al. Feb 2016 B2
9987164 Calhoun Jun 2018 B2
10195077 Calhoun et al. Feb 2019 B2
10265085 Zaidat Apr 2019 B2
10342699 Calhoun et al. Jul 2019 B2
20010001114 Tsugita et al. May 2001 A1
20020038103 Estrada et al. Mar 2002 A1
20020077656 Ginn et al. Jun 2002 A1
20020077658 Ginn Jun 2002 A1
20020087128 Paques et al. Jul 2002 A1
20020143291 Slater Oct 2002 A1
20020151922 Hogendijk et al. Oct 2002 A1
20020165573 Barbut Nov 2002 A1
20030023200 Barbut et al. Jan 2003 A1
20030023227 Zadno-Azizi et al. Jan 2003 A1
20030199802 Barbut Oct 2003 A1
20030199819 Beck Oct 2003 A1
20030203958 Kunz et al. Oct 2003 A1
20050149117 Khosravi et al. Jul 2005 A1
20060089618 McFerran et al. Apr 2006 A1
20060136022 Wong, Jr. et al. Jun 2006 A1
20060259132 Schaffer et al. Nov 2006 A1
20060276838 Wensel et al. Dec 2006 A1
20070026035 Burke et al. Feb 2007 A1
20080027519 Guerrero Jan 2008 A1
20080243229 Wallace et al. Oct 2008 A1
20090018455 Chang Jan 2009 A1
20090024072 Criado et al. Jan 2009 A1
20090030323 Fawzi et al. Jan 2009 A1
20090221961 Tal et al. Sep 2009 A1
20100076365 Riina et al. Mar 2010 A1
20100100045 Pravongviengkham et al. Apr 2010 A1
20100125244 McAndrew May 2010 A1
20100234884 Lafontaine et al. Sep 2010 A1
20110143993 Langer et al. Jun 2011 A1
20110152683 Gerrans et al. Jun 2011 A1
20110152998 Berez et al. Jun 2011 A1
20110160762 Hogendijk et al. Jun 2011 A1
20110274748 Robinson et al. Nov 2011 A1
20120046679 Patel et al. Feb 2012 A1
20120078287 Barbut Mar 2012 A1
20120101510 Lenker et al. Apr 2012 A1
20130035628 Garrison et al. Feb 2013 A1
20130197621 Ryan et al. Aug 2013 A1
20130281788 Garrison Oct 2013 A1
20140154246 Robinson et al. Jun 2014 A1
20140222066 Tegals Aug 2014 A1
20150025562 Dinh et al. Jan 2015 A1
20150032121 Janardhan et al. Jan 2015 A1
20150065804 Kleyman Mar 2015 A1
20150231378 Pepper Aug 2015 A1
20150272732 Tilson et al. Oct 2015 A1
20150313607 Zhadkevich Nov 2015 A1
20150359547 Vale et al. Dec 2015 A1
20150359549 Lenker et al. Dec 2015 A1
20150366580 Lenihan et al. Dec 2015 A1
20160166754 Kassab et al. Jun 2016 A1
20160213893 Franklin Jul 2016 A1
20160279385 Katsurada et al. Sep 2016 A1
20160317328 Berez et al. Nov 2016 A1
20170164963 Goyal Jun 2017 A1
20170239453 Kawakita et al. Aug 2017 A1
20170274179 Sullivan et al. Sep 2017 A1
20170326001 Franco et al. Nov 2017 A1
20170348120 Calhoun et al. Dec 2017 A1
20180132876 Zaidat May 2018 A1
20190192164 Parekh et al. Jun 2019 A1
20190388112 Nguyen et al. Dec 2019 A1
Foreign Referenced Citations (14)
Number Date Country
2 495 006 Sep 2012 EP
WO 9852639 Nov 1998 WO
WO 9853761 Dec 1998 WO
WO 0054673 Sep 2000 WO
WO 03018085 Mar 2003 WO
WO 2007103464 Sep 2007 WO
WO 2011156782 Dec 2011 WO
WO 2012162651 Nov 2012 WO
WO 2014022866 Feb 2014 WO
WO 2016109586 Jul 2016 WO
WO 2016149653 Sep 2016 WO
WO 2017156333 Sep 2017 WO
WO 2018053121 Mar 2018 WO
WO 2018106858 Jun 2018 WO
Non-Patent Literature Citations (39)
Entry
Written Opinion and International Search Report dated Mar. 29, 2018, of International Patent Application No. PCT/US2018/14766. (7 pages).
Altinbas, N.K. et al, “Effect of Carotid Artery Stenting on Ophthalmic Artery Flow Patterns,” Journal of Ultrasound Medicine, 2014; 33: pp. 629-638.
Ambarki, K. et al., “Blood Flow of Ophthalmic Artery in Healthy Individuals Determined by Phase-Contrast Magnetic Resonance Imaging,” Investigative Ophthalmology & Visual Science, 2013; 54: pp. 2738-2745.
Hwang, G. et al., “Reversal of Ischemic Retinopathy Following Balloon Angioplasty of a Stenotic Ophthalmic Artery.” Journal of Neuro-Ophthalmology 30.3, 2010, pp. 228-230.
Kane, A.G. et al., “Reduced Caliber of the Internal Carotid Artery: A Normal Finding with Ipsilateral Absence or Hypoplasia of the A1 Segment,” American Journal of Neuroradiology, 1996; 17: pp. 1295-1301.
Kawa, M.P. et al., “Complement System in Pathogenesis of AMD: Dual Player in Degeneration and Protection of Retinal Tissue,” Hindawi Publishing Corporation, Journal of Immunology Research, vol. 2014, Article ID 483960, 12 pages.
Klein, R. et al., “Vasodilators, Blood Pressure-Lowering Medications, and Age-Related Macular Degeneration,” American Academy of Ophthalmology, 2014, vol. 121, Issue 8, pp. 1604-1611.
Kooragayala, K. et al., “Quanitification of Oxygen Consumption in Retina Ex Vivo Demonstrates Limited Reserve Capacity of Photoreceptor Mitochondria,” Investigative Ophthalmology & Visual Science, 2015; 56: pp. 8428-8436.
Krejza, J. et al., “Carotid Artery Diameter in Men and Women and the Relation to Body and Neck Size,” Stroke, 2006; 3 pages.
Lanzino, G. et al., “Treatment of Carotid Artery Stenosis: Medical Therapy, Surgery, or Stenting?,” Mayo Clinic Proceedings, Apr. 2009; 84(4), pp. 362-368.
Michalinos, A. et al., “Anatomy of the Ophthalmic Artery: A Review concerning Its Modern Surgical and Clinical Applications,” Hindawi Publishing Corporation, Anatomy Research International, vol. 2015, Article ID 591961, 8 pages.
Paques, M. et al., “Superselective ophthalmic artery fibrinolytic therapy for the treatment of central retinal vein occlusion.” British Journal of Ophthalmology, 2000, 84: 1387-1391.
Tan, P.L. et al., “AMD and the alternative complement pathway: genetics and functional implications,” Human Genomics, 2016, 10:23, 13 pages.
Xu, H. et al., “Targeting the complement system for the management of retinal inflammatory and degenerative diseases,” European Journal of Pharmacology, 2016, 787, pp. 94-104.
Yamane, T. et al., “The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma,” International Journal of Clinical Oncology, Apr. 2004; vol. 9, Issue 2, pp. 69-73.
Zeumer, H. et al., “Local intra-arterial fibrinolytic therapy in patients with stroke: urokinase versus recombinant tissue plagminogen activator (r-TPA),” Neuroradiology, 1993; 35: pp. 159-162.
Zipfel, P.F., et al., “The Role of Complement in AMD,” Inflammation and Retinal Disease: Complement Biology and Pathology, Advances in Experimental Medicine and Biology, 2010, 703, pp. 9-24.
Examination Report No. 2 for AU Application No. 2013296195, dated Jun. 27, 2017 (6 pages).
Notice of Allowance for KR 20157005602, dated Sep. 25, 2017 (3 pages).
Loh, K. et al., “Prevention and management of vision loss relating to facial filler injections.” Singapore Medical Journal, 2016; 57(8): 438-443.
International Search Report and Written Opinion for International Application No. PCT/US2017/0051551, dated Dec. 15, 2017 (14 pages).
International Search Report and Written Opinion for International Application No. PCT/US2017/0052901, dated Dec. 8, 2017 (9 pages).
Bird, B. et al., “Anatomy, Head and Neck, Ophthalmic Arteries,” NCBI Bookshelf, a service of the National Library of Medicine, National Institutes of Health, Oct. 27, 2018, 5 pages. www.ncbi.nlm.nih.gov/books/NBK482317/.
Hattenbach, L. et al., “Experimental Endoscopic Endovascular Cannulation: A Novel Approach to Thrombolysis in Retinal Vessel Occlusion,” Investigative Ophthalmology & Visual Science, Jan. 2012, vol. 53, No. 1, pp. 42-46.
Khan, T.T. et al., “An Anatomical Analysis of the Supratrochlear Artery: Considerations in Facial Filler Injections and Preventing Vision Loss,” Aesthetic Surgery Journal, 2017, vol. 37(2), pp. 203-208.
Schumacher, M. et al., “Intra-arterial fibrinolytic therapy in central retinal artery occlusion,” Neuroradiology (1993) 35: pp. 600-605.
Schwenn, O.K. et al., “Experimental Percutaneous Cannulation of the Supraorbital Arteries: Implication for Future Therapy,” Investigative Ophthalmology & Visual Science, May 2005, vol. 46, No. 5, pp. 1557-1560.
Wang, R. et al., “Evaluation of Ophthalmic Artery Branch Retrograde Intervention in the Treatment of Central Retinal Artery Occlusion (CRAO),” Medical Science Monitor, 2017, 23: pp. 114-120.
Zhao, W. et al. “Three-Dimensional Computed Tomographic Study on the Periorbital Branches of the Ophthalmic Artery: Arterial Variations and Clinical Relevance,” Aesthetic Surgery Journal, 2018, pp. 1-9.
International Search Report and Written Opinion for corresponding PCT/US2013/053670, dated Dec. 26, 2013 (16 pp.).
Hayreh, S.S., “The Ophthalmic Artery III. Branches,” British Journal of Ophthalmology, 1962, 46, pp. 212-247.
International Search Report and Written Opinion for International Application No. PCT/US2018/031229, dated Jul. 27, 2018 (19 pages).
Mazur et al., Catheterization and Cardiovascular Diagnosis, vol. 31, Issue 1, Abstract (1994).
Aurboonyawat et al., “Indirect Carotid-Cavernous Sinus Fistulas Treated by Transvenous Approach Through the Superior Ophthalmic Vein: A Case Report and Technical Note,” Siriraj Med. J., vol. 59, pp. 191-194, 2007.
Kleintjes, “Forehead anatomy: Arterial variations and venous link of the midline forehead flap,” Journal of Plastic, Reconstructive & Aesthetic Surgery, vol. 60, Issue 6, pp. 593-606, 2007.
International Search Report and Written Opinion for International Application No. PCT/US2019/068758, dated May 29, 2020 (16 pages).
Extended European Search Report for EP 18745369.1, dated Nov. 18, 2020 (6 pages).
Hayreh et al., “Ocular Arterial Occlusive Disorders and Carotid Artery Disease,” American Academy of Ophthalmology, 2017; vol. 1, No. 1: pp. 12-18.
Hayreh et al., “The Ophthalmic Artery,” Brit. J. Ophthal., 1962; 46, 65: pp. 65-98.
Related Publications (1)
Number Date Country
20190380689 A1 Dec 2019 US
Provisional Applications (2)
Number Date Country
62525839 Jun 2017 US
62450257 Jan 2017 US